NEW YORK (GenomeWeb) – Mutations in the estrogen receptor gene ESR1 appear to be linked to more aggressive disease and poorer patient outcomes in individuals with estrogen receptor-positive metastatic breast cancer, according to a study published today in JAMA Oncology.